Trevi Therapeutics, Inc. (TRVI)
10.95
+0.65
(+6.31%)
USD |
NASDAQ |
Jan 22, 16:00
10.95
0.00 (0.00%)
After-Hours: 18:22
Trevi Therapeutics Total Liabilities (Quarterly): 9.568M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| CorMedix, Inc. | 376.73M |
| Arbutus Biopharma Corp. | 20.31M |
| Bristol Myers Squibb Co. | 78.29B |
| NovaBay Pharmaceuticals, Inc. | 1.853M |
| Palatin Technologies, Inc. | 8.218M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 199.36M |
| Shareholders Equity (Quarterly) | 189.79M |
| Debt to Equity Ratio | 0.0043 |
| Current Ratio | 21.93 |
| Net Debt Paydown Yield | 0.01% |